Posticy
Boost your SEO with Backlinks that are worth it
SR Ranko
Turn scattered startup information into focused action.
SR Booster
Submit your startup to 120+ top directories.

New Owner

Allergan - AqueSys

Allergan acquires AqueSys

Announced: September 03, 2015
Closed:        October 19, 2015

Type:           Acquisition
Disposition: Separate Entity
Status:         Complete

Amount:       $ 300,000,000

Acquisition News

Add News

Date Title
Oct 19, 2015 PRNewswire All - Allergan Successfully Completes AqueSys Acquisition, Adding XEN45 Minimally Invasive Implantable Shunt for Glaucoma
Allergan Successfully Completes AqueSys Acquisition, Adding XEN45 Minimally Invasive Implantable Shunt for Glaucoma
Oct 19, 2015 PRNewswire All - Allergan Successfully Completes AqueSys Acquisition, Adding XEN45 Minimally Invasive Implantable Shunt for Glaucoma
Allergan Successfully Completes AqueSys Acquisition, Adding XEN45 Minimally Invasive Implantable Shunt for Glaucoma
Sep 03, 2015 PRNewswire All - Allergan to Acquire Glaucoma Treatment Company AqueSys to Add Minimally Invasive Implantable Shunt to Eye Care Offering
Allergan to Acquire Glaucoma Treatment Company AqueSys to Add Minimally Invasive Implantable Shunt to Eye Care Offering

Allergan Other Acquisitions

Add Acquisition

Date Acquired Amount
Feb 13, 2017
Zeltiq
$ 2,470,000,000
Jan 09, 2017
Lysosomal Therapeutics
Undisclosed amount
Dec 20, 2016
LifeCell
$ 2,900,000,000
Nov 22, 2016
Chase Pharmaceuticals
$ 125,000,000
Oct 27, 2016
Motus Therapeutics
$ 200,000,000
Sep 20, 2016
Akarna Therapeutics
Undisclosed amount
View more acquisitions »